Cell and molecular biology of epidermal growth factor receptor
- PMID: 25376492
- DOI: 10.1016/B978-0-12-800177-6.00005-0
Cell and molecular biology of epidermal growth factor receptor
Abstract
The epidermal growth factor receptor (EGFR) has been one of the most intensely studied cell surface receptors due to its well-established roles in developmental biology, tissue homeostasis, and cancer biology. The EGFR has been critical for creating paradigms for numerous aspects of cell biology, such as ligand binding, signal transduction, and membrane trafficking. Despite this history of discovery, there is a continual stream of evidence that only the surface has been scratched. New ways of receptor regulation continue to be identified, each of which is a potential molecular target for manipulating EGFR signaling and the resultant changes in cell and tissue biology. This chapter is an update on EGFR-mediated signaling, and describes some recent developments in the regulation of receptor biology.
Keywords: Cancer; Endocytic trafficking; Epidermal growth factor receptor; Epithelial cells; ErbB family; Receptor tyrosine kinase.
Similar articles
-
Magnitude of Ubiquitination Determines the Fate of Epidermal Growth Factor Receptor Upon Ligand Stimulation.J Mol Biol. 2021 Oct 15;433(21):167240. doi: 10.1016/j.jmb.2021.167240. Epub 2021 Sep 8. J Mol Biol. 2021. PMID: 34508725
-
ErbB Receptors and Cancer.Methods Mol Biol. 2017;1652:3-35. doi: 10.1007/978-1-4939-7219-7_1. Methods Mol Biol. 2017. PMID: 28791631 Review.
-
Differential effects of EGFR ligands on endocytic sorting of the receptor.Traffic. 2009 Aug;10(8):1115-27. doi: 10.1111/j.1600-0854.2009.00943.x. Epub 2009 May 19. Traffic. 2009. PMID: 19531065 Free PMC article.
-
Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation.J Biol Chem. 2018 Feb 16;293(7):2288-2301. doi: 10.1074/jbc.M117.811299. Epub 2017 Dec 18. J Biol Chem. 2018. PMID: 29255092 Free PMC article.
-
EGF receptor trafficking: consequences for signaling and cancer.Trends Cell Biol. 2014 Jan;24(1):26-34. doi: 10.1016/j.tcb.2013.11.002. Epub 2013 Nov 29. Trends Cell Biol. 2014. PMID: 24295852 Free PMC article. Review.
Cited by
-
Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells.Cell Death Discov. 2024 Jan 4;10(1):2. doi: 10.1038/s41420-023-01776-5. Cell Death Discov. 2024. PMID: 38177097 Free PMC article.
-
Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review.
-
Trial Watch-Immunostimulation with cytokines in cancer therapy.Oncoimmunology. 2015 Dec 8;5(2):e1115942. doi: 10.1080/2162402X.2015.1115942. eCollection 2016 Feb. Oncoimmunology. 2015. PMID: 27057468 Free PMC article. Review.
-
The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades.Ther Adv Med Oncol. 2018 Feb 1;10:1758834017751635. doi: 10.1177/1758834017751635. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29434677 Free PMC article.
-
Two-pore channels affect EGF receptor signaling by receptor trafficking and expression.iScience. 2021 Jan 27;24(2):102099. doi: 10.1016/j.isci.2021.102099. eCollection 2021 Feb 19. iScience. 2021. PMID: 33644717 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous